Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries

Journal of Affective Disorders

Volumn 94, Issue 1-3, 2006, Pages 3-13

  Rihmer, Zoltán ^a   Akiskal, Hagop ^b  

^a NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antidepressant; RCT; Suicide; Suicide attempt

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; FLUOXETINE; LITHIUM; MAPROTILINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGGRESSION; AKATHISIA; AUTOMUTILATION; BEHAVIOR DISORDER; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE EXACERBATION; DRUG FORMULATION; DRUG POTENCY; DRUG SAFETY; DRUG USE; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HEART ARRHYTHMIA; HEART PROARRHYTHMIA; HOMICIDE; HUMAN; HYPERTHYMIA; HYPOMANIA; IATROGENIC DISEASE; MAJOR DEPRESSION; MANIA; MENTAL DISEASE; MENTAL INSTABILITY; PANIC; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PUBLIC HEALTH; RESTLESSNESS; REVIEW; RISK ASSESSMENT; SEX RATIO; SIDE EFFECT; STATISTICS; SUICIDAL BEHAVIOR; SUICIDE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ADVISORY COMMITTEES; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIPOLAR DISORDER; CHILD; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; HUMANS; INCIDENCE; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; SEROTONIN UPTAKE INHIBITORS; SUICIDE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33746227776     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.04.003     Document Type: Review

References (94)

1. Akiskal H.S. Developmental pathways to bipolarity: are juvenile-onset depressions pre-bipolar?. J. Am. Acad. Child Adolesc. Psych. 34 (1995) 754-763
2. Akiskal H.S. The prevalent clinical spectrum of bipolar disorders: Beyond DSM-IV. J. Clin. Psychopharmacol. 16 suppl 1 (1996) 4s-14s
3. Akiskal H.S., and Benazzi F. Delineating depressive mixed states: their therapeutic significance. Clini. Approaches Bipolar Disord. 2 (2003) 41-47
4. Akiskal H.S., and Benazzi F. Psychopathologic correlates of suicidal ideation in major depressive outpatients: is it all due to unrecognized bipolar depressive mixed states?. Psychopathology 38 (2005) 273-280
5. Akiskal H.S., and Mallya G. Criteria for the "soft" bipolar spectrum: treatment implications. Psychopharmacol. Bull. 23 (1987) 68-73
6. Akiskal H.S., and Pinto O. The evolving bipolar spectrum: prototypes I, II, III, IV. Psychiatr. Clin. North Am. 22 (1999) 517-534
7. Akiskal H.S., Bourgeois M.L., Angst J., Post R., Moller H.J., and Hirschfeld R.M.A. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J. Affect. Disord. 59 Suppl 1 (2000) 5s-30s
8. Akiskal H.S., Benazzi F., Perugi G., and Rihmer Z. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J. Affect. Disord. 85 (2005) 245-258
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR) (2000), American Psychiatric Association, Washington, DC
10. Angst J., Angst F., and Stassen H.H. Suicide risk in patients with major depressive disorder. J. Clin. Psychiatry 60 suppl 2 (1999) 57-62
11. Angst F., Stassen H.H., Clayton P.J., and Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J. Affect. Disord. 68 (2002) 167-181
12. Balázs J., Lecrubier Y., Csiszér N., Koszták K., and Bitter I. Prevalence and comorbidity of affective disorders in persons making suicide attempts in Hungary: importance of the first depressive episode and bipolar II diagnoses. J. Affect. Disord. 76 (2003) 113-119
13. Balázs J., Benazzi F., Rihmer Z., Rihmer A., Akiskal K.K., and Akiskal H.S. The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. J. Affect. Disord. 91 (2006) 133-138
14. Baldessarini R.J., Tondo L., and Hennen J. Lithium treatment and suicide risk in major affective disorders: update and new findings. J. Clin. Psychiatry 64 suppl 5 (2003) 44-52
15. Baldessarini R.J., Pompili M., and Tondo L. Suicidal risk in antidepressant drug trials. Arch. Gen. Psychiatry 63 (2006) 246-247
16. Barak Y., Olmer A., and Aizenberg D. Antidepressants reduce the risk of suicide among elderly depressed patients. Neurophychopharmacology 31 (2006) 178-181
17. Barbui C., Campomani A., D'Avanzo B., Negri E., and Gorattini S. Antidepressant drug use in Italy since the introduction of the SSRI's: national trends, regional differences and impact on suicide rates. Soc. Psychiatry Psychiatr. Epidemiol. 34 (1999) 152-156
18. Bauer M.S., Wisniewski S.R., Marangell L.B., Chessick C.A., Allen M.H., Dennehy E.B., Miklowitz D.J., Thase M.E., and Sachs G.S. Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). J. Clin. Psychiatry 67 (2006) 48-55
19. Beasley C.M., Dornseif B.E., Bosomworth J.C., Sayler M.E., Rampsey Jr. A.H., Heiligenstein J.H., Thompson V.L., Murphy D.J., and Masica D.N. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ 303 (1991) 685-692
20. Benazzi F. Which could be a clinically useful definition of depressive mixed state?. Prog. Neuro-psychopharmacol. Biol. Psychiatry 26 (2002) 1105-1111
21. Benazzi F. Depression with racing thoughts. Psychiatry Res. 120 (2003) 273-282
22. Benazzi F., and Akiskal H.S. Assessing the FDA's probable correlates of suicidality associated with antidepressants in adult clinical sample. J. Affect. Disord. (2006) 10.1016/j.jad.04.002
23. Benazzi F., Helmi S., and Bland L. Agitated depression: unipolar? Bipolar? Or both?. Ann. Clin. Psychiatry 14 (2002) 97-104
24. Bostwick J.M., and Pankratz V.S. Affective disorders and suicide risk: a reexamination. Am. J. Psychiatry 157 (2000) 1925-1932
25. Bottlender R., Rudolf D., Strauss A., and Möller H.-J. Mood-stabilizers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients. J. Affect. Disord. 63 (2001) 79-83
26. Bottlender R., Sato T., Kleindienst N., Strausz A., and Moller H.-J. Mixed depressive features predict maniform switch during treatment of depression in bipolar I disorder. J. Affect. Disord. 78 (2004) 149-152
27. Busch K.A., Fawcett J., and Jacobs D.G. Clinical correlates of inpatient suicide. J. Clin. Psychiatry 64 (2003) 14-19
28. Cheung A.H., Emslie G.J., and Mayes T.L. The use of antidepressants to treat depression in children and adolescents. CMAJ 174 (2006) 193-200
29. Culpepper L., Davidson J.R.T., Dietrich A.J.M., Goodman W.K., Kroenke K., and Schwenk T.L. Suicidality as a possible side effect of antidepressant treatment. J. Clin. Psychiatry 65 (2004) 742-749
30. Dilsaver S.C., and Akiskal H.S. High rate of unrecognized bipolar mixed states among destitute Hispanic adolescents referred for "major depressive disorder". J. Affect. Disord. 84 (2005) 179-186
31. Dunner D.L. Clinical consequences of under-recognized bipolar spectrum disorder. Bipolar Disord. 5 (2003) 456-464
32. FDA: http://www.fda.gov/cder/drug/antidepressants/default.htm (accessed 13 October 2004).
33. Faedda G.L., Baldessarini R.J., Glovinsky I.P., and Austin N.B. Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review. J. Affect. Disord. 82 (2004) 149-158
34. Fawcett J., Busch K.A., Jacobs D., Kravitz H.M., and Fogg L. Suicide: a four-pathway clinical-biochemical model. Ann. N. Y. Acad. Sci. 836 (1997) 288-301
35. Fergusson D., Doucette S., Glass K.C., Shapiro S., Healy D., Hebert P., and Hutton B. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ 330 (2005) 396-402
36. Furukawa T.A., Strener D.L., and Young L.T. Is antidepressant-benzodiazepine combination therapy clinically more useful? A meta-analytic study. J. Affect. Disord. 65 (2001) 173-177
37. Ghaemi S.N., Ko J.Y., and Goodwin F.K. "Cade's Disease" and beyond: Misdiagnosis, antidepressant use, and proposed definition for bipolar spectrum disorder. Can. J. Psychiatry 47 (2002) 125-134
38. Golomb B.A., Kane T., and Dimsdale J.E. Severe irritability associated with statin cholesterol-lowering drugs. QJM 97 (2004) 229-235
39. Goodwin F.K., and Jamison K.R. Manic-Depressive Illness (1990), Oxford University Press, New York
40. Grunebaum M.F., Ellis S.P., Li S., Oquendo M.A., and Mann J.J. Antidepressants and suicide risk in the United States, 1985-1999. J. Clin. Psychiatry 65 (2004) 1456-1462
41. Hall W.D., Mant A., Mitchell P.B., Rendle V.A., Hickie I.B., and McManus P. Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis. BMJ 326 (2003) 1008-1012
42. Hammad T.A., Laughren T., and Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch. Gen. Psychiatry 63 (2006) 332-339
43. Haykal R., and Akiskal H.S. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management. J Clin. Psychiatry 60 (1999) 508-518
44. Healy D. Lines of evidence on the risk of suicide with selective serotonine reuptake inhibitors. Psychother. Psychosom. 72 (2003) 71-79
45. Helgason T., Tómasson H., and Zoéga T. Antidepressants and public health in Iceland. Time series analysis of national data. Br. J. Psychiatry 184 (2004) 157-162
46. Isacsson G. Suicide prevention-a medical breakthrough?. Acta Psychiatr. Scand. 102 (2000) 113-117
47. Isacsson G., Holmgren P., and Ahlner J. Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic data based study of 14857 suicides. Acta Psychiatr. Scand. 111 (2005) 286-290
48. Isometsa E.T., Henriksson M.M., Aro H.M., and Lonnqvist J. Suicide in bipolar disorder in Finland. Am. J. Psychiatry 151 (1994) 1020-1024
49. Kahn A., Warner H.A., and Brown W.A. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials. An analysis of the Food and Drug Administration Database. Arch. Gen. Psychiatry 57 (2000) 311-317
50. Kahn A., Kahn S.R., Leventhal R.M., and Brown W.A. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database. Int. J. Neuropsychopharmacol. 4 (2001) 113-118
51. Kahn A., Kahn S., Kolts R., and Brown W.A. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am. J. Psychiatry 160 (2003) 790-792
52. Kallner G., Lindelius R., Petterson U.J., Stockman O., and Tham A. Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it. Pharmacopsychiatry 33 (2000) 8-13
53. Kelly C.B., Ansari T., Rafferty T., and Stevenson M. Antidepressant prescribing and suicide rate in Northern Ireland. Eur. Psychiatr. 18 (2003) 325-328
54. Kessler R.C. Comorbidity of unipolar and bipolar depression with other psychiatric disorders in a general population survey. In: Tohen M. (Ed). Comorbidity in Affective Disorders (1999), Marcel Dekker, New York 1-25
55. Kessler R.C., Berglund P., Borges B., Nock M., and Want P.S. Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. JAMA 293 (2005) 2487-2495
56. Khuri R., and Akiskal H.S. Suicide prevention: the necessity of treating contributory psychiatric disorders. Psychiatr. Clin. North Am. 6 (1983) 193-207
57. Kim Y.-K., Lee H.-J., Kim J.-Y., Yoon D.-K., Choi S.-H., and Lee M.-S. Low serum cholesterol is correlated to suicidality in a Korean sample. Acta Psychiatr. Scand. 105 (2002) 141-148
58. Koukopoulos A., and Koukopoulos A. Agitated depression as a mixed state and the problem of melancholia. Psychiatr. Clin. North Am. 22 (1999) 547-564
59. Koukopoulos A., Faedda G., Proietti R., D'Amico S., de Pisa E., and Simonetto C. Mixed depressive syndrome. Encephale 18 (1992) 19-21
60. Kujawa M.J., and Nemeroff C.B. The biology of bipolar disorder. Bipolar Disorders-100 Years after Manic-Depressive Insanity (2000), Kluwer Academic Publishers, Dordrecht 281-314
61. Leon A.C., Keller M.B., Warshaw M.G., Mueller T.I., Solomon D.A., Coryell W., and Endicott J. Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects. Am. J. Psychiatry 156 (1999) 195-201
62. Ludwig J., and Marcotte D.E. Anti-depressants, suicide, and drug regulation. J. Policy Anal. Manage. 24 (2005) 249-272
63. Luoma J.B., Martin C.E., and Pearson J.I. Contact with mental health and primary care providers before suicide: a review of the evidence. Am. J. Psychiatry 159 (2002) 909-916
64. Maj M., Pirozzi R., Magliano L., and Bartoli L. Agitated depression in bipolar I disorder: prevalence, phenomenology, and outcome. Am. J. Psychiatry 160 (2003) 2134-2140
65. Mann J.J., Emslie G., Balderssarini R.J., Beardslee W., Fawcett J.A., Goodwin F.K., Leon A.C., Meltzer H.Y., Ryan N.D., Shaffer D., and Watgner K.D. ACNP task force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology 31 (2006) 473-492
66. March J., Silva S., Petrycki s., Curry J., Wells K., Fairbank J., Burns B., Domino M., McNulty S., Vitiello B., and Severe J. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: treatment for Adolescents with Depression Study (TADS) randomized cantrolled trial. JAMA 292 (2004) 807-820
67. Maser J.D., Akiskal H.S., Zeller P., Scheftner W., Mueller T., Endicott J., Solomon D., and Clayton P. Can temperament identify affectively ill patients who engage in lethal or near-lethal suicidal behavior? A 14-year prospective study. Suicide Life-Threat. Behav. 32 (2002) 10-32
68. Montgomery S.A., Dunner D.L., and Dunbar G.C. Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur. Neuropsychopharmacol. 5 (1995) 5-13
69. Nutt D.J. Care of depressed patients with anxiety symptoms. J. Clin. Psychiatry 60 (1999) 23-27
70. O'Leary D., Paykel E., Todd C., and Vardulaki K. Suicide in primary affective disorders revisited: a systematic review by treatment era. J. Clin. Psychiatry 62 (2001) 804-811
71. Olfson M., Shaffer D., Marcus S.C., and Greenberg T. Relationship between antidepressant medication treatment and suicide in adolescents. Arch. Gen. Psychiatry 60 (2003) 978-982
72. Podrid P.J. Proarrhythmia, a serious complication of antiarrhythmic drugs. Curr. Cardiol. Rep. 1 (1999) 289-296
73. Rihmer Z. Can better recognition and treatment of depression reduce suicide rates ? A brief review. Eur. Psychiatr. 16 (2001) 406-409
74. Rihmer Z. Decreasing national suicide rates-Fact or fiction?. World J. Biol. Psychiatry 5 (2004) 55-56
75. Rihmer Z., and Kiss K. Bipolar disorders and suicidal behaviour. Bipolar Disord. 4 Suppl. 1 (2002) 21-25
76. Rihmer Z., Barsi J., Arató M., and Demeter E. Suicide in subtypes of primary major depression. J. Affect. Disord. 18 (1990) 221-225
77. Rihmer Z., Rutz W., and Pihlgren H. Depression and suicide on Gotland. An intensive study of all suicides before and after a depression-training programme for general practitioners. J. Affect. Disord. 35 (1995) 147-152
78. Rihmer Z., Szádóczky E., Füredi J., Kiss K., and Papp Z. Anxiety disorders comorbidity in bipolar I, bipolar II and unipolar major depression: results from a population-based study in Hungary. J. Affect. Disord. 67 (2001) 175-179
79. Rosack, J., 2005. New data show declines in antidepressant prescribing. Psychiatry News 40, 1 [source NCD Health, 2005].
80. Rutz W., von Knorring L., and Walinder J. Frequency of suicide on Gotland after systematic postgraduate education of general practitioners. Acta Psychiatr. Scand. 80 (1989) 151-154
81. Rutz W., Walinder J., von Knorring L., Rihmer Z., and Pihlgren H. Prevention of depression and suicide by education and medication: impact on male suicidality. An update from the Gotland study. Int. J. Psychiatry Clin. Pract. 1 (1997) 39-46
82. Rouillon F., Serrurier D., Miller H.D., and Gerard M.-J. Prophylactic efficacy of maprotiline on unipolar depression relapse. J. Clin. Psychiatry 52 (1991) 423-431
83. Sato T., Bottlender R., Schroter A., and Moller H.-J. Frequency of manic symptoms during a depressive episode and unipolar 'depressive mixed state' as bipolar spectrum. Acta Psychiatr. Scand. 107 (2003) 268-274
84. Sharma V., Khan M., and Smith A. A closer look at treatment resistant depression: Is it due to a bipolar diathesis?. J. Affect. Disord. 84 (2005) 251-257
85. Shi L., Thiebaud P., and McCombs J.S. The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program. J. Affect. Disord. 82 (2004) 373-383
86. Simon G.E., Savarino J., Operskalski B., and Wang P.S. Suicide risk during antidepressant treatment. Am. J. Psychiatry 163 (2006) 41-47
87. Smith W.T., Londborg P.D., Glaudin V., Painter J.R., and Summit Research Network. Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?. J. Affect. Disord. 70 (2002) 251-259
88. Tondo L., Baldessarini R.J., Hennen J., Floris G., Silvetti F., and Tohen M. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J. Clin. Psychiatry 59 (1998) 405-414
89. Viner M.W., Chen Y., Bakshi I., and Kamper P. Low-dose risperidone augmentation of antidepressants in nonpsychotic depressive disorders with suicidal ideation. J. Clin. Psychopharmacol. 23 (2003) 104-106
90. Warshaw M.G., and Keller M. The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. Am. J. Psychiatry 57 (1996) 158-166
91. Whittington C.J., Kendall T., Fonagy P., Cottrell D., Cotgrove A., and Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. The Lancet 363 (2004) 1341-1345
92. Wilens T.E., Biederman J., Kwon A., Chase R., Greenberg L., Mick E., and Spencer T.J. A systematic chart review of the nature of psychiatric adverse effects in children and adolescents treated with selective serotonin reuptake inhibitors. J. Child Adolesc. Psychopharmacol. 13 (2003) 143-152
93. Yerevanian B.I., Koek R.J., and Mintz J. Lithium, anticonvulsants and suicidal behavior in bipolar disorder. J. Affect. Disord. 73 (2003) 223-228
94. Yerevanian B.I., Koek R.J., Feusner J.D., Hwang S., and Mintz J. Antidepressants and suicidal behaviour in unipolar depression. Acta Psychiatr. Scand. 110 (2004) 452-458